Healthcare provider profile · identity verified

Warren Hampton Cave, APRN

Nurse Practitioner · KAUFMAN, TX · NPI 1639446610

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Furosemide	Furosemide	472	63
Atorvastatin Calcium	Atorvastatin Calcium	459	90
Gabapentin	Gabapentin	395	81
Levothyroxine Sodium	Levothyroxine Sodium	320	51
Lisinopril	Lisinopril	301	73
Potassium Chloride	Potassium Chloride	298	51
Pantoprazole Sodium	Pantoprazole Sodium	273	45
Sertraline Hcl	Sertraline Hcl	257	35
Amlodipine Besylate	Amlodipine Besylate	242	61
Metformin Hcl	Metformin Hcl	235	46
Eliquis	Apixaban	217	27
Losartan Potassium	Losartan Potassium	214	60
Clopidogrel	Clopidogrel Bisulfate	161	27
Tramadol Hcl	Tramadol Hcl	160	50
Trazodone Hcl	Trazodone Hcl	155	41
Tamsulosin Hcl	Tamsulosin Hcl	150	37
Simvastatin	Simvastatin	146	28
Escitalopram Oxalate	Escitalopram Oxalate	145	14
Montelukast Sodium	Montelukast Sodium	143	22
Metoprolol Succinate	Metoprolol Succinate	139	38
Tizanidine Hcl	Tizanidine Hcl	134	54
Metoprolol Tartrate	Metoprolol Tartrate	133	32
Omeprazole	Omeprazole	129	41
Donepezil Hcl	Donepezil Hcl	128	13
Mirtazapine	Mirtazapine	122	12
Prednisone	Prednisone	121	83
Rosuvastatin Calcium	Rosuvastatin Calcium	121	22
Duloxetine Hcl	Duloxetine Hcl	104	13
Fluticasone Propionate	Fluticasone Propionate	101	35
Divalproex Sodium	Divalproex Sodium	100	suppressed
Clonazepam	Clonazepam	93	21
Levetiracetam	Levetiracetam	91	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	90	30
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	89	18
Carvedilol	Carvedilol	82	29
Meloxicam	Meloxicam	81	37
Nystatin	Nystatin	80	32
Ropinirole Hcl	Ropinirole Hcl	76	12
Zolpidem Tartrate	Zolpidem Tartrate	76	20
Pravastatin Sodium	Pravastatin Sodium	75	13
Pioglitazone Hcl	Pioglitazone Hcl	73	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	70	18
Albuterol Sulfate Hfa	Albuterol Sulfate	69	28
Anastrozole	Anastrozole	66	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	65	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	62	31
Latanoprost	Latanoprost	62	suppressed
Novolog Flexpen	Insulin Aspart	61	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	61	suppressed
Pregabalin	Pregabalin	60	12
Rytary	Carbidopa/Levodopa	60	suppressed
Amoxicillin	Amoxicillin	58	54
Hydroxyzine Hcl	Hydroxyzine Hcl	58	12
Xarelto	Rivaroxaban	57	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	55	suppressed
Allopurinol	Allopurinol	53	19
Baclofen	Baclofen	50	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	49	suppressed
Buspirone Hcl	Buspirone Hcl	48	12
Famotidine	Famotidine	48	suppressed
Paroxetine Hcl	Paroxetine Hcl	48	suppressed
Bupropion Hcl	Bupropion Hcl	47	suppressed
Azithromycin	Azithromycin	45	43
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	44	suppressed
Ozempic	Semaglutide	44	13
Dicyclomine Hcl	Dicyclomine Hcl	43	suppressed
Ondansetron Hcl	Ondansetron Hcl	42	29
Oxybutynin Chloride	Oxybutynin Chloride	42	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	42	suppressed
Citalopram Hbr	Citalopram Hydrobromide	41	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	17
Glimepiride	Glimepiride	39	suppressed
Memantine Hcl	Memantine Hcl	39	suppressed
Spironolactone	Spironolactone	39	suppressed
Glipizide	Glipizide	38	19
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	suppressed
Alprazolam	Alprazolam	37	15
Amiodarone Hcl	Amiodarone Hcl	37	suppressed
Celecoxib	Celecoxib	37	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	28
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	35	13
Cephalexin	Cephalexin	33	28
Acetazolamide	Acetazolamide	32	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	32	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	31	25
Topiramate	Topiramate	31	suppressed
Lorazepam	Lorazepam	30	suppressed
Divalproex Sodium Er	Divalproex Sodium	29	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Terbinafine Hcl	Terbinafine Hcl	29	17
Carbamazepine	Carbamazepine	28	suppressed
Diazepam	Diazepam	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	15
Fluconazole	Fluconazole	27	16
Metformin Hcl Er	Metformin Hcl	27	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Novolin R Flexpen	Insulin Regular, Human	26	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Digoxin	Digoxin	25	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	25	suppressed
Methylprednisolone	Methylprednisolone	25	22
Olanzapine	Olanzapine	25	suppressed
Roflumilast	Roflumilast	25	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Linzess	Linaclotide	24	suppressed
Myrbetriq	Mirabegron	24	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	24	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	18
Primidone	Primidone	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	17
Atenolol	Atenolol	22	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	22	19
Temazepam	Temazepam	22	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Clobetasol Propionate	Clobetasol Propionate	20	suppressed
Doxepin Hcl	Doxepin Hcl	20	suppressed
Haloperidol	Haloperidol	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Bumetanide	Bumetanide	19	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	19	suppressed
Verapamil Hcl	Verapamil Hcl	19	suppressed
Diltiazem Hcl	Diltiazem Hcl	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	18	suppressed
Lidocaine	Lidocaine	18	suppressed
Movantik	Naloxegol Oxalate	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Albuterol Sulfate	Albuterol Sulfate	17	15
Cefuroxime	Cefuroxime Axetil	17	suppressed
Lactulose	Lactulose	17	suppressed
Methocarbamol	Methocarbamol	17	11
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Risperidone	Risperidone	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Cyclosporine	Cyclosporine	15	suppressed
Hydroxyurea	Hydroxyurea	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	15
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Amantadine	Amantadine Hcl	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Naproxen	Naproxen	13	suppressed
Tamoxifen Citrate	Tamoxifen Citrate	13	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Estradiol	Estradiol	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Nystop	Nystatin	12	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error